Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I. J. Jacobs

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 1999
Differences between hereditary and sporadic ovarian cancerR P Zweemer, R H Verheijen, F H Menko, et al.
Journal of the National Cancer Institute|September 15, 1993
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancerM F Kohler, J R Marks, R W Wiseman, et al.
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 28, 2002
Histopathologic features of genetically determined ovarian cancerP A Shaw, J R McLaughlin, R P Zweemer, et al.
Lancet (London, England)|April 27, 1999
Screening for ovarian cancer: a pilot randomised controlled trialI J Jacobs, S J Skates, N MacDonald, et al.
Cancer|November 1, 1995
Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancerJ A Hurteau, R P Woolas, I J Jacobs, et al.
Journal of the National Cancer Institute|November 3, 1993
Elevation of multiple serum markers in patients with stage I ovarian cancerR P Woolas, F J Xu, I J Jacobs, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 28, 2001
Survival analysis in familial ovarian cancer, a case control studyR P Zweemer, R H Verheijen, J W Coebergh, et al.
British Journal of Cancer|August 22, 2002
A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancerP O Van Trappen, A Ryan, M Carroll, et al.
Lancet (London, England)|February 24, 2001
Molecular quantification and mapping of lymph-node micrometastases in cervical cancerP O Van Trappen, V G Gyselman, D G Lowe, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 1999
Differences between hereditary and sporadic ovarian cancerR P Zweemer, R H Verheijen, F H Menko, et al.
Journal of the National Cancer Institute|September 15, 1993
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancerM F Kohler, J R Marks, R W Wiseman, et al.
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 28, 2002
Histopathologic features of genetically determined ovarian cancerP A Shaw, J R McLaughlin, R P Zweemer, et al.
Lancet (London, England)|April 27, 1999
Screening for ovarian cancer: a pilot randomised controlled trialI J Jacobs, S J Skates, N MacDonald, et al.
Cancer|November 1, 1995
Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancerJ A Hurteau, R P Woolas, I J Jacobs, et al.
Journal of the National Cancer Institute|November 3, 1993
Elevation of multiple serum markers in patients with stage I ovarian cancerR P Woolas, F J Xu, I J Jacobs, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 28, 2001
Survival analysis in familial ovarian cancer, a case control studyR P Zweemer, R H Verheijen, J W Coebergh, et al.
British Journal of Cancer|August 22, 2002
A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancerP O Van Trappen, A Ryan, M Carroll, et al.
Lancet (London, England)|February 24, 2001
Molecular quantification and mapping of lymph-node micrometastases in cervical cancerP O Van Trappen, V G Gyselman, D G Lowe, et al.
Pageof 7